|
Axis-Shield and Bio-Rad launch new anti-CCP test |
|
Friday, 22 January 2010 |
Bio-Rad Laboratories, Inc. and Axis-Shield plc has launched BioPlex 2200 anti-CCP test for the early detection of rheumatoid arthritis. The assay, which will run on Bio-Rad's BioPlex 2200 system, measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have superior specificity in the diagnosis of rheumatoid arthritis. The BioPlex 2200 anti-CCP kit is based on Axis-Shield's proprietary anti-CCP technology.
|
